Efficacy of risperidone treatment in smith-magenis syndrome (del 17 pll. 2)

Psychiatria Danubina

Volumn 19, Issue 3, 2007, Pages 189-192

  Niederhofer, Helmut ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Behavioral phenotype; Chromosome del 17 pll. 2; Mental retardation; Risperidone; SMS

Indexed keywords

CARBAMAZEPINE; METHYLPHENIDATE; PAROXETINE; RISPERIDONE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; AGGRESSION; ANGER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; CASE REPORT; CHECKLIST; CHROMOSOME 17; CHROMOSOME DELETION; CLINICAL FEATURE; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; GENETIC ANALYSIS; HAMILTON SCALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MALFORMATION SYNDROME; MENTAL DEFICIENCY; MOLECULAR GENETICS; PATHOGENESIS; PHENOTYPE; SCHOOL REENTRY; SLEEP DISORDER; SMITH MAGENIS SYNDROME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ABNORMALITIES, MULTIPLE; ADOLESCENT; AGGRESSION; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL RETARDATION; RISPERIDONE; SYNDROME;

EID: 34948843016     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Allen WP, Phelan MC, Stevenson RE: Smith-Magenis syndrome: Report of five patients. Proc Greenwood Genet Ctr 1991; 10:18-22.
2. Amman MG, Singh NN, Stewart AW, Field CJ: Psychometric characteristics of the Aberrant Behavior Checklist. Am J Ment Def 1985; 99:492-502.
3. Barnicoat AJ, Moller HU, Palmer RW, Russell-Eggitt I, Winter RM: An unusual presentation of Smith.Magenis syndrome with iris dysgenesis. Clin Dysmorph 1996; 5:153-158.
4. Behjati F, Mullarkey M, Bergbaum A, Berty AC, Docherty Z: Chromosome deletion 17p11.2 (Smith-Magenis syndome) in seven new patients, four of whom had heen referred for fragile-X investigation. Clin Genet 1997; 51:71-74.
5. Chen RM, Lupski JR, Greenberg F, and Lewis RA: Ophthalmic manifestations of Smith-Magenis syndrome. Ophthalmology 1996: 103(7):1084-1091.
6. Colley AF, Leversha MA, Voullaire LE, Rogers JG: Five cases demonstrating the distinctive behavioral features of chromosome deletion 17(pll.2p11.2) . J Paediatr Child Health 1990; 26:17-21.
7. Fan YS, Farrell SA: Prenatal diagnosis of interstitual deletion of 17 (Pl 1.2p121.2) (Smith-Magenis syndrome). J Paediatr Child Health 1994; 26:17-21.
8. Finucane BM, Jaeger ER, Kurtz MB, Weinstein M, Scott CI: Eye abnomalities in the Smith-Magenis contiguous gene deletion syndrome. Am J Med Genet 1993a; 45:443-6.
9. Finucane BM. Kurtz M, Babu VR, Scott CI: Mosaicism for deletion 17p11.2 in 5 boy with the Smith-Magenis syndrome. Am J Med Genet 1993b; 45:447-9.
10. Finucane, BM, Konar D, Givler BH, Kurtz MB, and Scott, LI: The spasmodic upper body squeeze: A characteristic behavior in SmithMagenis syndrome. Dev Med Child Neurol 1994; 36:70433.
11. Fischer H, Oswald HP, Duba HD, Doczy L. Simma B, Utermann G, Hass OA: Constitutional interstitial deletion of 17(pll.2) (SmithMagenis syndrome): A clinically recognizable microdeletion syndrome: Report of two cases and review of the literature. Klin Paediatr 1993; 205:162-166.
12. Greenberg F. Guzzetta V, De Oca-Luna RM, Magenis RE, Smith ACM, Richter SF. Kondo I, Dobyns WB, Pate PI, Lupski J: Molecular analysis of the Smith.Magenis syndrome: A possible contiguous.gene syndrome associated with del(17)(pll.2). Am J Hum Genet 1991; 49:1207-1218.
13. Greenberg R. Lewis RA, Potocki L, Glaze D. Parke J. Killian J, Murpha MA, Williamson D, Brown F, Dutton R, McCluggage C, Friedman E, Sulek M, Lupski JR: Multi-disciplinary clinical study of Smith Magenis syndrome (deletion 17p11.2,). Am J Med Genet 1996; 62:247-254.
14. Gropman AL, Duncan WC, Smith AC, Neurologic and Developmental Features of the Smith-Magenis Syndrome (del 17p11.2), Pediatric Neurology 34(5), 337-50.
15. Hamill MA, Roberts SH, Maguire MJ, Laurence KM: Interstitial deletion of 17p11.2: Case report and review. Ann Genet 1990; 31:3688.
16. Jan JE and H Espezel: Melatonin treatment of chronic sleep disorders. Dev Med Child Neurol 1995; 37:279-281.
17. Jan JE, Esperzel H, Appieton RE: The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994; 36:97-107.
18. Lockwood D, Hecht F, Dowman C, Hecht BK, Rizkallah TH, Goodwin TM, Allanson J: Chromosome sub-band 17p11.2 deletion: A minute deletion syndrome. J Med Genet 1988; 25:732-737.
19. Masuno M, Asano J, Arai M, Kuwahara T, Orii T: Interstitial deletion of 17p11.2 with brain abnormalities. Clin Genet 1992; 41:278-280.
20. Meinecke P: Confirmation of a particular but non specific metacarpophalangeal pattern profile in patients with the Smith-Magenis -syndrome due to interstitial deletion of 17p. Am J Med Genet 1993; 45:441-42.
21. Moncla A, Livet MO, Auger M, Mattei JF, Mattei MG, Firaud F: Smith.Magenis syndome: A new contiguous gene syndrome. Report of three new cases. J Med Genet 1991; 28:627-632.
22. Patel SR, Bartley JA: Interstitial deletion of the short arm of chromsome 17. Hum Genet 1984; 67:237-238.
23. Popp DW, Johnson CP, Stratton RF: An additional case of deletion 17p11.2. Am J Med Genet 1987; 26:493-495.
24. Potacki L, Reiter RJ. Glaze D, Lupski JR: Twenty-four hour urinary excretion of 6-suiphatoxy-melstonin in Smith-Magenis Syndrome. American College of Medical Genetics Conference 1997; A31.
25. Smith ACM, Mc Gavran L, Waldstein G: Deletion of the 17 short arm in two patients with facial clefts. Am J Hum Genet 1982; 34(Suppl):A410.
26. Smith ACM, McGavran L, Robinson J, Waldstein G, Macfarlane J, Zonona J, Reiss J, Lahr M. Allen L, Magenis E: Interstitial deletion of (17)(pll.2p11.2) in nine patients. Am J Med Genet 1986; 24:393-414.
27. Stratton RF, Dobyns WA, Greenberg F, De Sana JR Moore C, Fidone G, Runge GH. et al: Interstitial deletion of(17)(p11.2p11.2): Report of six additional patients with a new Chromosome deletion syndrome. Am J Med Genet 1986; 24:421-432.
28. Zori RT, Lupski JR. Heju Z, Greenberg F, Killian JM, Gray BA, Driscoll DJ, Patel Pl, Zackowski JL: Clinical, cytogenetic, and molecular evidence for an infant with Smith-Magenis syndrome born from a mother having a mosaic 17p11.2p12 deletion. Am J Med Genet 1993; 47:504-511.